The Centers for Medicare & Medicaid Services yesterday approved a state of Washington-developed emergency demonstration project to adjust its Medicaid program temporarily in order to combat COVID-19.

Using a Section 1115(a) waiver, which is retroactive to March 1, 2020, CMS is permitting Washington to target Medicaid services on a geographic basis that is less than statewide; to vary the amount, duration and scope of services based on population needs; to provide different services to different beneficiaries in the same eligibility group, or different services to beneficiaries in the categorically needy and medically needy groups; and to allow the state to triage access to long-term services and supports based on highest need.

CMS said Washington also is granted new expenditure authority, including paying higher rates for some home and community-based services.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned…
Headline
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
A report by the Department of Health and Human Services Office of the Inspector General found that many Medicare Advantage and Medicaid managed care plans…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…